Browse studies

Find your next paid study

1,513 recruiting studies matching your filters

tACS Brain Neuromodulation for Sensory and Motor Recovery After Neurological Impairments

The overall goal is to investigate the effectiveness of a novel intervention - transcranial alternating current stimulation (tACS) for neuropathic pain managem…

Neuropathic Pain Management

Estimated

~$10 – $6,250

The University of Texas Health Science Center, HoustonNCT06029075

Observational

A Type 2 Hybrid Effectiveness-implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Coastal Alabama

The purpose of this study is to adapt and evaluate a combination intervention that includes: (1) a data-driven approach to directed community-based HIV testing…

HIVHIV Linkage to CareHIV Testing+1 more

Estimated

~$10 – $6,250

University of Alabama at BirminghamNCT05384145

Acceptability of Soy Milk as a Calcium-Rich Beverage in School Children in New York City Public Schools

NYC Public Schools is testing offering soy milk alongside dairy milk on the lunch line for all students during the month of May at select school sites to under…

Food AcceptanceSoy MilkSchools+6 more

Estimated

~$10 – $1,125

Physicians Committee for Responsible MedicineNCT07595562

Using Aquagenic Wrinkling to Predict CF Carrier State

The goal of this observational study is to determine whether an aquagenic wrinkling procedure (i.e., soaking hands in a water bath for up to 20 minutes) can be…

Aquagenic Wrinkling of PalmsCarrier State

Estimated

~$10 – $750

University of IowaNCT06831110

Phase 1

A Phase 1 Clinical Trial of 64Cu-DOTA A2 scFv-Fc2 DM (64Cu-DOTA-A2DM) Positron Emission Tomography in Patients With Metastatic PSCA-Expressing Pancreatic Cancer

This clinical trial tests the safety, side effects, best dose and feasibility of using 64Cu-DOTA A2 scFv-Fc2 DM with positron emission tomography for the imagi…

Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+1 more

Estimated

~$10 – $6,250

City of Hope Medical CenterNCT07608627

Observational

Open Label Feasibility Dose Escalation Study to Evaluate the Safety of Sarah Nanotechnology System, With Alternating Magnetic Field (AMF) Application in Patients With Advanced Metastatic Solid Tumors.

This is a sequential, dose-escalation, non-randomized, prospective, early feasibility trial. The goal of this clinical trial is to gather information on the sa…

Metastatic Solid TumorsStage 4 Cancer

Estimated

~$10 – $8,750

New Phase Ltd.NCT07224464

Phase 2

A Randomized, Multicenter, Open-Label, Phase 2 Study of Givastomig (TJ033721) in Combination With Nivolumab and Chemotherapy Versus Nivolumab and Chemotherapy in Participants With Previously Untreated CLDN18.2 Positive and PD-1L Positive Locally Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Junction Adenocarcinoma

The goal of this clinical trial is to learn if givastomig in combination with standard therapy works to treat adults with cancer in the stomach and/or esophagu…

Solid TumorAdvanced CancerMetastatic Cancer+3 more

Estimated

~$10 – $8,750

I-Mab Biopharma US LimitedNCT07432295

Phase 3

Phase III Double Blinded Trial of Immune-Based Therapy With a Live Biotherapeutic MO-03 or Placebo for Frontline Therapy of Advanced Clear Cell Renal Cell Carcinoma [BioFront Trial]

This phase III trial compares the effect of adding live biotherapy, MO-03, to standard of care (SOC) immunotherapy, including ipilimumab, nivolumab, axitinib, …

Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more

Estimated

~$10 – $7,500

SWOG Cancer Research NetworkNCT07383441

Phase 1

MC210501 Differences in Immunological Effects of Vitamin D Replacement Among Black/ African American (AA) Prostate Cancer Patients With Localized Versus Metastatic Disease

This early phase I is to find out how common vitamin D insufficiency is among African American patients with a history of prostate cancer that has not spread t…

Localized Prostate CarcinomaStage IV Prostate Cancer AJCC v8Locally Recurrent Prostate Carcinoma+1 more

Estimated

~$10 – $6,250

Mayo ClinicNCT05045066

Phase 4

Intranasal Sphenopalatine Ganglion Blockade as a Non-invasive, Opioid-sparing Treatment for Headaches Following Aneurysmal Subarachnoid Hemorrhage

In patients with bleeding from a brain aneurysm, severe headache is the most common complaint. However, the pain is difficult to treat. The use of standard pai…

Aneurysmal Subarachnoid Hemorrhage (aSAH)Headache

Estimated

~$10 – $6,250

Wright State UniversityNCT07116408

Phase 1

A Phase 1/2, Open-label Study of PD-1 Knockout Tumor-infiltrating Lymphocytes (IOV-4001) in Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

This is a study to investigate the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced no…

Unresectable MelanomaMetastatic MelanomaStage III Non-small Cell Lung Cancer+1 more

Estimated

~$10 – $8,750

Iovance Biotherapeutics, Inc.NCT05361174

Phase 2

Impact of Microbiome Modulation With CBM588 in Combination With Pembrolizumab for Adjuvant Therapy of High-Risk, Resected Renal Cell Carcinoma (RCC)

This phase II trial compares the effect of adding a Live Biotherapeutic Product called CBM588 to pembrolizumab versus pembrolizumab alone in preventing return …

Clear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8+2 more

Estimated

~$10 – $6,250

City of Hope Medical CenterNCT07037004